Latest news
AstraZeneca receives CDSCO approval of additional indication for trastuzumab deruxtecan - BioSpectrum IndiaBioSpectrum India · Sun, 09 Aug 2026 17:43:21 GMTAstraZeneca Gets CDSCO Nod to Market Enhertu for New Breast Cancer Indication - Medical DialoguesMedical Dialogues · Sat, 08 Aug 2026 15:30:45 GMTAstraZeneca Pharma gets CDSCO nod to market Enhertu for additional indication - Business StandardBusiness Standard · Sat, 08 Aug 2026 12:20:02 GMTAstraZeneca Pharma Gets CDSCO Nod To Sell Enhertu For Breast Cancer - NDTV ProfitNDTV Profit · Sat, 08 Aug 2026 09:00:27 GMTAstraZeneca Pharma India gets CDSCO nod to import and distribute breast cancer treatment drug - CNBC TV18CNBC TV18 · Tue, 28 Jul 2026 11:17:19 GMTAstraZeneca gets CDSCO nod for expanded Enhertu indication in HER2-positive breast cancer - Indian Pharma PostIndian Pharma Post · Tue, 28 Jul 2026 07:00:00 GMTAstraZeneca Pharma India gets CDSCO approval for Enhertu in breast cancer - scanx.tradescanx.trade · Tue, 28 Jul 2026 07:00:00 GMTAstraZeneca Pharma India receives CDSCO approval for HER2-positive stage II or III early breast cancer treatment - BioSpectrum IndiaBioSpectrum India · Tue, 28 Jul 2026 07:00:00 GMT